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1. Congenital ostial coronary artery atresia/hypoplasia should be a part of the differential 
diagnosis particularly in young patients presenting with a totally occluded coronary artery and no 
cardiovascular risk factors. 
2. Thrombolysis can be a good choice for treatment of STEMI if primary PCI has failed. 
3. Patients with suspicion of anomalous coronary arteries should perform CT angiography (CTA) 
to confirm originated sites, anatomic route and whether complicated with other congenital 
malformation. 
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Background. Cormatrix is an innovation in bioengineering, introduced in the medical world in 
2013. The material is based on the extracellular matrix derived from the porcine intestine 
submucosa, allowing for tissue restructure and growth in the "site" where it is used. The 
composition consists of collagen, glycosaminoglycans, glycoproteins, proteoglycans and growth 
factors VEGF, FGF. The superior characteristics are given by acellularity, resistance to infection, 
anti-inflammatory effect and immunomodulator, the most important element being the reactivity 
depending on the impulse from the tissue where it is involved. 
Case report. At the Institute of Cardiovascular and Transplant Diseases in Targu Mures, 
Cormatrix has been in used since 2013 and has been useful as a biocompatible tissue in arterial 
switch procedures of transposition of great vessels. A 12 days old patient diagnosed with 
transposition of great vessels was received by Institute of Cardiovasculare and Transplant 
Diseases from Targu Mures for a arterial switch surgery. The surgery implies total 
cardiopulmonary by-pass and at 26 Celsius degrees in the operating theater the great vessels are 
cut from their emerging. The coronary arteries are excised from the future pulmonary artery and 
reimplanted in neo-aortic wall; the resulting parietal defect after the coronary arteries excision is 
repaired with a Cormatrix patch plasty. Literature showed that in 30% of cases where pericardial 
patch was used it led to a pulmonary supravalvular stenosis. The post-surgery echographics at 3 
months, 6 months and 1 years where Cormatrix was used showed no change in circulatory flow 
in the pulmonary cormatrix patch segment. 
Conclusions. In conclusion Cormatrix patch seems to have better results in reconstruction of the 
pulmonary artery wall defects in transposition of great vessels surgery because it has a high level 
of biocompatibility and a better reintegration in the vessel tissues . 
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Background. Sleep apnea is a disorder characterized by pauses in breathing or periods of 
shallow breathing during sleep. There are three forms of sleep apnea: obstructive (OSA), central 
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(CSA), and a combination of the two called mixed. OSA affects 1 to 6% of adults and 2% of 
children, but CSA affects less than 1% of people. 
Case report. Patient X, 58 years old, of female, was admitted at the Institute of Cardiology with 
mixed (inspiratory and expiratory) dyspnea at minimal effort, ankle swelling, general weakness, 
dizziness. The patient suffers from arterial hypertension during 14-year with maximum levels 
180/90 mmHg, working blood pressure being - 130/80 mmHg. At home regular treatment with 
tab. Bisoprolol 2.5 mg in the morning, tab. Aspirin 75 mg/day, tab. Losartan 50 mg in the 
evening, tab. Torasemidi 10 mg in the morning, over a day. The general condition worsened the 
last month when signs of congestive heart failure progressed. The echocardiographical 
examination revealed severe cardiomegaly (LA - 50 mm, LV - 60 mm, RA - 51 mm, RV - 40 
mm), preserved left ventricular function (EF - 58%), reduced right ventricular function (TAPSE - 
16 mm), severe pulmonary hypertension (PASP - 140 mmHg). To determine the cause of the 
pulmonary hypertension, a number of investigations were performed. Pulmonary artery 
angiography by computed tomography revealed pulmonary artery enlargement (40 mm) and 
dilated intrapulmonary arteries, but no data on thrombosis. Spirography has revealed severe 
changes in the function of external respiratory organs, being restrictive. Laboratory analyzes 
excluded the systemic sclerodermia (ANA-negative, Anti Scl-70 antibodies – 1.5 U/ml, Anti 
Centromer B antibodies – 0.3 U/ml) and normal values of D-dimers (0.24 ng/ml) excluded the 
presence of venous thrombosis. To exclude the presence of Sleep Apnea Syndrome, cardio-
respiratory polygraphy was performed. A severe form of Sleep Apnea-Hypopnea Syndrome was 
recorded, with the Apnea-Hypopnea Index (AHI) – 84.3/hour, with severe intermittent and 
continue nocturnal hypoxemia in close correlation with respiratory events, having a Desaturation 
Index (DI) – 82 6/hour. Average SaO2 – 69.6%, SaO2 minimum – 42%, SaO2 <90% = 07 hours 
50 min 48 sec.  
Conclusions. After 10 days of complex treatment with diuretics, direct and indirect 
anticoagulants, nitrates, angiotensin II receptor blockers, beta-adrenoblockers, continuous 
oxygen therapy, and CPAP + Oxygen therapy, the general condition improved: the mixed 
dyspnoea at minimal effort was reduced, general weakness , dizziness disappeared as well as the 
ankle swelling, and pulmonary artery systolic pressure decreased from 140 mmHg to 100 
mmHg.  
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Background. Choledocolithiasis is a late complication in the evolution of biliary lithiasis. More 
frequently, the main bile duct approach is performed by new miniinvasive methods.  
Case report. A 38 y/o female was diagnosed and treated in SOROKA Medical Center 
Beersheba in 2016. The patient was afebrile, haemodynamically stable, yet presented jaundice. 
The abdomen was soft, mildly tender at palpation, with a negative Murphy’s sign. Blood tests 
identified: WBC 4.6 x 109/L, AST 258 IU/L, ALT 352 IU/L, billirubin 77 umol/L, alkaline 
phosphatase 258 IU/L. The ultrasound investigation detected a dilated CBD (14 mm) containing 
two stones. MRCP confirms two ductal stones of 8 and 10 mm, and a dilated duct. ERCP 
identified two stones of 8 and 10 mm that couldn’t be removed, so a stent was placed and a 
